Ngoc-Quynh-Nhu Nguyen
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Cancer, Hypoxia, and Metabolism, Growth Hormone and Insulin-like Growth Factors, Cardiovascular Issues in Pregnancy, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy(2013)489 cited
- → PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin(2014)105 cited
- → The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis(2015)54 cited
- → The Antiangiogenic Factor, 16-kDa Human Prolactin, Induces Endothelial Cell Cycle Arrest by Acting at Both the G0–G1 and the G2–M Phases(2005)52 cited
- → The Angiostatic 16K Human Prolactin Overcomes Endothelial Cell Anergy and Promotes Leukocyte Infiltration via Nuclear Factor-κB Activation(2007)45 cited
- → Inhibition of Tumor Growth and Metastasis Establishment by Adenovirus-mediated Gene Transfer Delivery of the Antiangiogenic Factor 16K hPRL(2007)34 cited
- → Prolactin/growth hormone–derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis(2006)29 cited
- → Antiangiogenic liposomal gene therapy with 16K human prolactin efficiently reduces tumor growth(2009)25 cited
- → The Antiangiogenic 16K Prolactin Impairs Functional Tumor Neovascularization by Inhibiting Vessel Maturation(2011)19 cited
- → Erratum: Corrigendum: PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin(2015)2 cited